185 related articles for article (PubMed ID: 15049151)
1. [Use of biologically active supplement containing omega-3 polyunsaturated fatty acids in patients with type 2 diabetes mellitus].
Isaev VA; Panchenko VM; Liutova LV; Karabasova MA
Vopr Pitan; 2004; 73(1):16-9. PubMed ID: 15049151
[TBL] [Abstract][Full Text] [Related]
2. [Influence polyunsaturated fatty acids omega-3 on coagulation and fibrinolysis systems in patients with NIDDM].
Panchenko VM; Karabasova MA; Liutova LV; Togoev AM; Ershov AA; Chernova GI; Isaev VA
Klin Med (Mosk); 2002; 80(2):40-3. PubMed ID: 11898721
[TBL] [Abstract][Full Text] [Related]
3. [Effects of tycveinol on the lipid transport system and hemostasis and fibrinolysis systems in patients with ischemic heart disease].
Panchenko VM; Liutova LV; Karabasova MA; Ershov AA; Isaev VA
Klin Med (Mosk); 2002; 80(9):54-6. PubMed ID: 12416228
[TBL] [Abstract][Full Text] [Related]
4. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
J Nutr Biochem; 2006 Jun; 17(6):379-84. PubMed ID: 16214329
[TBL] [Abstract][Full Text] [Related]
5. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study.
De Luis DA; Conde R; Aller R; Izaola O; González Sagrado M; Perez Castrillón JL; Dueñas A; Romero E
Eur Rev Med Pharmacol Sci; 2009; 13(1):51-5. PubMed ID: 19364085
[TBL] [Abstract][Full Text] [Related]
6. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of effects of diet therapy including eiconol or linseed oil on several parameters of lipid metabolism in patients with type 2 diabetes mellitus].
Meshcheriakova VA; Plotnikova OA; Sharafetdinov KhKh; Alekseeva RI; Mal'tsev GIu; Kulakova SN
Vopr Pitan; 2001; 70(2):28-31. PubMed ID: 11494668
[TBL] [Abstract][Full Text] [Related]
8. [The effect of diets containing omega-3 polyunsaturated fatty acids on biochemical indicators and the fatty acid composition of the cell membranes in patients with ischemic heart disease and hereditary hyperlipidemia].
Samsonov MA; Levachev MM; Pogozheva AV; Korf II; Abbakumov AS
Vopr Med Khim; 1992; 38(3):22-4. PubMed ID: 1413642
[TBL] [Abstract][Full Text] [Related]
9. [Long-term administration of tyquanol in the treatment of patients with ischemic heart disease in combination with hyperlipidemia].
Panchenko VM; Ershov AA; Isaev VA
Klin Med (Mosk); 2003; 81(3):40-2. PubMed ID: 12698850
[TBL] [Abstract][Full Text] [Related]
10. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J
Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698
[TBL] [Abstract][Full Text] [Related]
11. [Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance].
Gapparova KM; Pogozheva AV; Kulakova SN; Tutel'ian VA
Vopr Pitan; 2000; 69(1-2):46-9. PubMed ID: 10943007
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
13. [Predicting effectiveness of omega-3 polyunsaturated fatty acid dietary treatment of patients with ischemic heart disease].
Endakova EA; Novgorodtseva TP; Kozycheva EV
Vopr Pitan; 2000; 69(1-2):37-40. PubMed ID: 10943004
[TBL] [Abstract][Full Text] [Related]
14. [Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus].
Panchenko VM; Ershov AA; Isaev VA; ZImovchenko GS; Chernova GI
Klin Med (Mosk); 2001; 79(6):47-9. PubMed ID: 11521381
[TBL] [Abstract][Full Text] [Related]
15. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
Mostad IL; Bjerve KS; Lydersen S; Grill V
Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
[TBL] [Abstract][Full Text] [Related]
16. Fat food for a bad mood. Could we treat and prevent depression in Type 2 diabetes by means of omega-3 polyunsaturated fatty acids? A review of the evidence.
Pouwer F; Nijpels G; Beekman AT; Dekker JM; van Dam RM; Heine RJ; Snoek FJ
Diabet Med; 2005 Nov; 22(11):1465-75. PubMed ID: 16241908
[TBL] [Abstract][Full Text] [Related]
17. [Experience in the use of eiconol (a complex of unsaturated fatty acids) in non-insulin-dependent diabetes mellitus].
Lazebnik LB; Vertkin AL; Malichenko SB; Li ED; Konev IuV; Romanovskaia TV; Goncharov LF
Klin Med (Mosk); 1996; 74(3):29-33. PubMed ID: 8926697
[TBL] [Abstract][Full Text] [Related]
18. [Cholesterol metabolism in patients with ischemic heart disease with varying supplies of omega-3 polyunsaturated fatty acids].
Samsonov MA; Liapkov BG; Abbakumov AS; Kiseleva TV; Pogozheva AV
Vopr Med Khim; 1994; 40(5):55-9. PubMed ID: 7839675
[TBL] [Abstract][Full Text] [Related]
19. [Christmas tree ornament cataract--an indication for disordered lipid metabolism?].
Anders N; Wollensak J
Klin Monbl Augenheilkd; 1992 Jul; 201(1):30-3. PubMed ID: 1513124
[TBL] [Abstract][Full Text] [Related]
20. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
